12 Jul Veoza and Liver Damage: Beware of the Risks of the Biologic Drug During Menopause
The European Medicines Agency (EMA) has issued a safety warning regarding the drug Veoza (fezolinetant), used to treat vasomotor symptoms of menopause, such as hot flashes and night sweats. According to the Pharmacovigilance Risk Assessment Committee (PRAC), there is a risk of severe liver damage...